Guggenheim Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-44,347
| Closed | -$7.33M | – | 2279 |
|
|
2021
Q2 | $7.33M | Buy |
44,347
+12,825
| +41% | +$2.14M | 0.04% | 514 |
|
|
2021
Q1 | $4.83M | Sell |
31,522
-4,895
| -13% | -$665K | 0.03% | 641 |
|
|
2020
Q4 | $4.57M | Sell |
36,417
-9,436
| -21% | -$1.06M | 0.03% | 615 |
|
|
2020
Q3 | $4.65M | Sell |
45,853
-6,329
| -12% | -$645K | 0.03% | 556 |
|
|
2020
Q2 | $5.08M | Buy |
52,182
+8,792
| +20% | +$818K | 0.04% | 513 |
|
|
2020
Q1 | $3.6M | Sell |
43,390
-8,414
| -16% | -$821K | 0.04% | 573 |
|
|
2019
Q4 | $5.76M | Sell |
51,804
-27,368
| -35% | -$2.82M | 0.04% | 559 |
|
|
2019
Q3 | $7.86M | Buy |
79,172
+19,321
| +32% | +$1.92M | 0.06% | 395 |
|
|
2019
Q2 | $5.93M | Sell |
59,851
-7,253
| -11% | -$692K | 0.05% | 509 |
|
|
2019
Q1 | $7.4M | Sell |
67,104
-4,417
| -6% | -$462K | 0.06% | 408 |
|
|
2018
Q4 | $6.58M | Buy |
71,521
+14,110
| +25% | +$1.43M | 0.06% | 427 |
|
|
2018
Q3 | $6.33M | Sell |
57,411
-2,996
| -5% | -$312K | 0.04% | 592 |
|
|
2018
Q2 | $5.64M | Buy |
60,407
+6,595
| +12% | +$568K | 0.04% | 639 |
|
|
2018
Q1 | $4.47M | Buy |
53,812
+135
| +0.3% | +$12K | 0.01% | 1080 |
|
|
2017
Q4 | $4.89M | Sell |
53,677
-20,327
| -27% | -$1.69M | 0.01% | 1050 |
|
|
2017
Q3 | $5.64M | Buy |
74,004
+10,450
| +16% | +$790K | 0.01% | 994 |
|
|
2017
Q2 | $4.77M | Sell |
63,554
-2,004
| -3% | -$139K | 0.01% | 1045 |
|
|
2017
Q1 | $4.28M | Buy |
65,558
+3,083
| +5% | +$182K | 0.01% | 1115 |
|
|
2016
Q4 | $3.44M | Sell |
62,475
-12,966
| -17% | -$712K | 0.01% | 1256 |
|
|
2016
Q3 | $4.26M | Sell |
75,441
-5,087
| -6% | -$249K | 0.01% | 1102 |
|
|
2016
Q2 | $3.36M | Sell |
80,528
-3
| -0% | -$138 | 0.01% | 1227 |
|
|
2016
Q1 | $3.44M | Buy |
+80,531
| New | +$3.4M | 0.01% | 1210 |
|
Other funds holding PRAH
Guggenheim Capital's PRAH Position: Q3 2021 in Review
Guggenheim Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 44,347 shares — an estimated $7.33M sold.
Guggenheim Capital first reported a position in PRAH in Q1 2016 and held it in 22 quarters. The position peaked at $7.86M in Q3 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Guggenheim Capital reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Guggenheim Capital sold 44,347 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $7.33M.
- Guggenheim Capital first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 22 quarters.
- Guggenheim Capital's PRA Health Sciences, Inc. position peaked at $7.86M in Q3 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.